Mangoceuticals (MGRX) said Friday it has signed an agreement to acquire the intellectual property and related assets of Canada-based pouch innovation firm Smokeless Technology.
Financial terms of the transaction were not disclosed.
The acquisition will allow Mangoceuticals to expand into the oral pouch delivery market and will also cover Smokeless Technology's product formulations, know-how, distribution and supplier relationships, Mangoceuticals said.
The company said it plans to integrate Smokeless Technology's stimulant formulations with pharmaceutical ingredients to be sold under its MangoRx and PeachesRx brands.
Mangoceuticals shares were down more than 11% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.